Promising New Drug - Cyclosporin A

Researchers at the University of Florida are working toward a treatment to curtail the secondary cell death which follows severe brain trauma. Early signs show that administration of the common chemotherapy drug Cyclosporin A within 12 hours of injury interrupts the chain of events that can lead to worsening of brain injury in the first day or two following trauma. Tests on animals show great promise in reducing swelling and regulation of calcium induced damage.